These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2293512)

  • 21. Juridical and liability reflexes of bone marrow processing.
    Flores A
    Haematologica; 1991 Mar; 76 Suppl 1():50-1. PubMed ID: 1864554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Legal issues in dermatology: informed consent, complications and medical malpractice.
    Goldberg DJ
    Semin Cutan Med Surg; 2007 Mar; 26(1):2-5. PubMed ID: 17349556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.
    Rosenmayr A; Hartwell L; Egeland T;
    Bone Marrow Transplant; 2003 Apr; 31(7):539-45. PubMed ID: 12692618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
    Dodson KL; Coppo PA; Confer DL
    Clin Transpl; 1999; ():121-7. PubMed ID: 11038630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical-legal issues associated with organ donation and transplantation. Part II. Living donors.
    Rosen L
    Todays OR Nurse; 1985 Aug; 7(8):32-3. PubMed ID: 3850670
    [No Abstract]   [Full Text] [Related]  

  • 26. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation.
    Avital I; Moreira AL; Klimstra DS; Leversha M; Papadopoulos EB; Brennan M; Downey RJ
    Stem Cells; 2007 Nov; 25(11):2903-9. PubMed ID: 17690178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicolegal problems associated with organ and tissue transplantations.
    Rose EF
    Leg Med; 1982; ():85-100. PubMed ID: 7121189
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychosocial issues. Unanswered questions in the use of bone marrow transplantation for treatment of hemoglobinopathies.
    Secundy MG
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):76-9. PubMed ID: 8311176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor registries for bone marrow transplantation. Technology Assessment Meeting Statement, May 13-15, 1985. National Institutes of Health.
    Int J Technol Assess Health Care; 1985; 1(3):729-38. PubMed ID: 10300790
    [No Abstract]   [Full Text] [Related]  

  • 31. [Unrelated bone marrow transplantation b. Bone Marrow Donor Registry. Nagoya Bone Marrow Transplantation Group].
    Mizuno S; Morishima Y
    Rinsho Ketsueki; 1990 May; 31(5):620-4. PubMed ID: 2395213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The central registry of bone marrow donors and the program for bone marrow transplantation from unrelated donors--20 months' experience].
    Koza V; Bártová A; Herynková R; Svojgrová M; Pittrová H
    Vnitr Lek; 1994 Jul; 40(7):416-9. PubMed ID: 8073656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical and legal aspects of liver transplantation.
    Millard CE
    Health Prog; 1985 Mar; 66(2):40-2, 50. PubMed ID: 10299940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow processing: the role of standardized practice.
    Ross RE; Jeter EK
    Prog Clin Biol Res; 1994; 389():737-45. PubMed ID: 7700940
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of donor hematolymphoid cells after rat-limb composite grafting.
    Ajiki T; Takahashi M; Inoue S; Sakuma Y; Oyama S; Kaneko T; Hakamata Y; Murakami T; Kume A; Kariya Y; Hoshino Y; Kobayashi E
    Transplantation; 2003 Mar; 75(5):631-6. PubMed ID: 12640301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Perkins HA; Kollman C; Howe CW
    Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor bone marrow transplantation: chimerism and tolerance.
    Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J
    Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transplantation: economic, ethical, and social issues.
    Durbin M
    Pediatrics; 1988 Nov; 82(5):774-83. PubMed ID: 3054784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank].
    Matsumoto K; Horibe K; Akatsuka Y; Minami S; Matsuyama T; Hirabayashi N; Tanimoto M; Yamada H; Sobue R; Morishima Y
    Rinsho Ketsueki; 1994 Aug; 35(8):729-37. PubMed ID: 7933558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red cell salvage and reinfusion in pediatric bone marrow donors.
    Kletzel M; Olszewski M; Danner-Koptik K; Coyne K; Haut P
    Bone Marrow Transplant; 1999 Aug; 24(4):385-8. PubMed ID: 10467327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.